HYHHF:OTC-Hygeia Healthcare Holdings Co Ltd (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 5

Change

0.00 (0.00)%

Market Cap

USD 3.14B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Hygeia Healthcare Holdings Co., Limited offers oncology healthcare services in the People's Republic of China. The company owns and operates private for-profit hospitals that offers oncology healthcare services, such as radiotherapy, chemotherapy, surgery, and targeted therapy, as well as cancer diagnosis, treatment, and rehabilitation. It also provides radiotherapy services to third-party hospitals, including radiotherapy center consulting services, licensing of radiotherapy equipment for use in the radiotherapy centers, and maintenance and technical support services for radiotherapy equipment. In addition, the company provides management services to private not-for-profit hospitals, as well as supply chain services; sells pharmaceutical, medical consumables, and medical equipment to third parties; and produces proprietary SRT equipment. The company was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
FSNUF Fresenius SE & Co. KGaA

N/A

USD 20.89B
BDUUY Bangkok Dusit Medical Services..

N/A

USD 13.86B
FMCQF Fresenius Medical Care AG & Co..

N/A

USD 12.25B
RMYHY Ramsay Health Care Ltd ADR

-0.36 (-5.40%)

USD 6.16B
RYHTY Ryman Healthcare Ltd ADR

-0.43 (-2.99%)

USD 2.06B
AEVIF Aevis Victoria SA

N/A

USD 1.69B
DNTCF dentalcorp Holdings Ltd.

N/A

USD 1.16B
RHKJF RHÖN-KLINIKUM Aktiengesellsch..

N/A

USD 0.82B
PFSMF Perfect Medical Health Managem..

N/A

USD 0.70B
EXETF Extendicare Inc

+0.13 (+1.90%)

USD 0.56B

ETFs Containing HYHHF

PPLN:CA Global X Pipelines & Ener.. 8.59 % 0.00 %

-0.02 (-0.19%)

N/A
HOG:CA 8.34 % 0.64 %

N/A

N/A
CIF:CA iShares Global Infrastruc.. 3.19 % 0.72 %

-0.07 (-0.19%)

CAD 0.47B
RDOG ALPS REIT Dividend Dogs E.. 2.30 % 0.00 %

-0.05 (-0.19%)

USD 0.01B
PSCF Invesco S&P SmallCap Fina.. 1.30 % 0.29 %

+0.20 (+-0.19%)

USD 0.02B
CVY Invesco Zacks Multi-Asset.. 1.26 % 0.65 %

+0.05 (+-0.19%)

USD 0.12B
TQCD:CA TD Q Canadian Dividend ET.. 0.00 % 0.00 %

-0.04 (-0.19%)

CAD 0.38B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 3.14B 92% A 82% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.